My journey at Day One: embracing AI and human intelligence
Joel Jitell, Global Head of Operations, reflects on joining Day One and why human oversight is essential to keep bias out of AI-driven research.
Watch our latest webinar: Who can you trust? A pharma leader’s guide to vetting AI for insights
View NowOur thinking
Insights, strategy, and perspectives from the Day One team
Joel Jitell, Global Head of Operations, reflects on joining Day One and why human oversight is essential to keep bias out of AI-driven research.
Three case studies from our EPHMRA paper show how analytical and GenAI tools uncover new insight, from synthetic personas to voice sentiment.
Back from the Intellus Institute, Claire Macchia explains why GenAI will transform healthcare insights faster than any shift before it.
Elise Roche explores the unconscious emotions that shape oncologists' prescribing decisions.
Research Director Emma Eden looks back on her first year at Day One and shares what she's most excited about next.
An early experiment from 2023 in which ChatGPT wrote this entire article on the future of GenAI in market research, prompts included.
Voice emotion analysis of 351 YouTube videos reveals how the COVID-19 pandemic shifted public and expert emotions towards vaccination.